Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.

Rempis EM, Schnack A, Decker S, Braun V, Rubaihayo J, Tumwesigye NM, Busingye P, Harms G, Theuring S.

BMC Pregnancy Childbirth. 2017 Mar 7;17(1):82. doi: 10.1186/s12884-017-1263-2.

2.

Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial.

Siou K, Walmsley SL, Murphy KE, Raboud J, Loutfy M, Yudin MH, Silverman M, Ladhani NN, Serghides L.

Pilot Feasibility Stud. 2016 Aug 12;2:49. eCollection 2016. Erratum in: Pilot Feasibility Stud. 2017 Apr 28;3:21.

3.

Perinatal Antiretroviral Exposure and Prevented Mother-to-child HIV Infections in the Era of Antiretroviral Prophylaxis in the United States, 1994-2010.

Little KM, Taylor AW, Borkowf CB, Mendoza MC, Lampe MA, Weidle PJ, Nesheim SR.

Pediatr Infect Dis J. 2017 Jan;36(1):66-71.

PMID:
27749662
4.

Disclosing in utero HIV/ARV exposure to the HIV-exposed uninfected adolescent: is it necessary?

Jao J, Hazra R, Mellins CA, Remien RH, Abrams EJ.

J Int AIDS Soc. 2016 Oct 13;19(1):21099. doi: 10.7448/IAS.19.1.21099. eCollection 2016.

5.

Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth.

Jao J, Freimanis L, Mussi-Pinhata MM, Cohen RA, Monteiro JP, Cruz ML, Branch A, Sperling RS, Siberry GK; NISDI LILAC Protocol.

Am J Perinatol. 2017 Apr;34(5):486-492. doi: 10.1055/s-0036-1593536. Epub 2016 Oct 7.

6.

Antiretroviral Therapy and Pregnancy Outcomes in Developing Countries: A Systematic Review.

Alemu FM, Yalew AW, Fantahun M, Ashu EE.

Int J MCH AIDS. 2015;3(1):31-43. Review.

7.

Mitochondrial toxicity and caspase activation in HIV pregnant women.

Hernandez S, Moren C, Catalán-García M, Lopez M, Guitart-Mampel M, Coll O, Garcia L, Milisenda J, Justamante A, Gatell JM, Cardellach F, Gratacos E, Miro Ò, Garrabou G.

J Cell Mol Med. 2017 Jan;21(1):26-34. doi: 10.1111/jcmm.12935. Epub 2016 Aug 30.

8.
9.

In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.

Hofer CB, Keiser O, Zwahlen M, Lustosa CS, Frota AC, de Oliveira RH, Abreu TF, Carvalho AW, Araujo LE, Egger M.

Pediatr Infect Dis J. 2016 Jan;35(1):71-7. doi: 10.1097/INF.0000000000000926.

10.

Duration of cART Before Delivery and Low Infant Birthweight Among HIV-Infected Women in Lusaka, Zambia.

Bengtson AM, Chibwesha CJ, Westreich D, Mubiana-Mbewe M, Vwalika B, Miller WC, Mapani M, Musonda P, Pettifor A, Chi BH.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):563-9. doi: 10.1097/QAI.0000000000000909.

11.

Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.

Vannappagari V, Koram N, Albano J, Tilson H, Gee C.

BJOG. 2016 May;123(6):910-6. doi: 10.1111/1471-0528.13542. Epub 2015 Aug 12.

12.

Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.

Money DM, Wagner EC, Maan EJ, Chaworth-Musters T, Gadawski I, van Schalkwyk JE, Forbes JC, Burdge DR, Albert AY, Lohn Z, Côté HC; Oak Tree Clinic Research Group.

PLoS One. 2015 Aug 6;10(8):e0135041. doi: 10.1371/journal.pone.0135041. eCollection 2015.

13.

Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.

Samuel M, Bradshaw D, Perry M, Chan SY, Dhairyawan R, Byrne L, Smith K, Zhou J, Short CE, Naftalin C, Offodile N, Mandalia S, Roedling S, Shah R, Brook G, Poulton M, Rodgers M, Sarner L, Noble H, Hay P, Anderson J, Natha M, Hawkins D, Taylor G, de Ruiter A.

Infect Dis Obstet Gynecol. 2014;2014:961375. doi: 10.1155/2014/961375. Epub 2014 Sep 25.

14.

Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.

Koss CA, Natureeba P, Plenty A, Luwedde F, Mwesigwa J, Ades V, Charlebois ED, Clark TD, Achan J, Ruel T, Nzarubara B, Kamya MR, Havlir DV, Cohan D.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):128-35. doi: 10.1097/QAI.0000000000000281.

15.

Predictors of adverse pregnancy outcomes in women infected with HIV in Latin America and the Caribbean: a cohort study.

Kreitchmann R, Li SX, Melo VH, Fernandes Coelho D, Watts DH, Joao E, Coutinho CM, Alarcon JO, Siberry GK.

BJOG. 2014 Nov;121(12):1501-8. doi: 10.1111/1471-0528.12680. Epub 2014 Mar 7.

16.

Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Read JS, Huo Y, Patel K, Mitchell M, Scott GB.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):92-102. doi: 10.1093/jpids/pis036. Epub 2012 May 3.

17.

Antiretrovirals in pregnancy: a note of caution.

Watts DH, Mofenson LM.

J Infect Dis. 2012 Dec 1;206(11):1639-41. doi: 10.1093/infdis/jis581. Epub 2012 Oct 12. No abstract available.

18.

Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, Powis K, Dryden-Peterson S, Creek T, Jimbo W, Madidimalo T, Makhema J, Essex M, Shapiro RL.

J Infect Dis. 2012 Dec 1;206(11):1695-705. doi: 10.1093/infdis/jis553. Epub 2012 Oct 12.

19.

Incidence of and socio-biologic risk factors for spontaneous preterm birth in HIV positive Nigerian women.

Ezechi OC, David AN, Gab-Okafor CV, Ohwodo H, Oladele DA, Kalejaiye OO, Ezeobi PM, Gbajabiamila TA, Adu RA, Oke B, Musa ZA, Ekama SO, Ilesanmi O, Odubela O, Somefun EO, Herbertson EC, Onwujekwe DI, Ujah IA.

BMC Pregnancy Childbirth. 2012 Sep 9;12:93.

20.

Small-for-gestational-age births in pregnant women with HIV, due to severity of HIV disease, not antiretroviral therapy.

Aaron E, Bonacquisti A, Mathew L, Alleyne G, Bamford LP, Culhane JF.

Infect Dis Obstet Gynecol. 2012;2012:135030. doi: 10.1155/2012/135030. Epub 2012 Jun 20.

Supplemental Content

Support Center